ALDH1A1 and invasive ductal breast carcinoma: In conclusion, the current study has highlighted the importance of the ALDH1 status in translating cancer stem cell research into clinical practice, and further identified ALDH1 as a potential therapeutic target in invasive ductal carcinoma.